*	OR T1 T2
R1	Has_value Arg1:T3 Arg2:T4	
R2	multi Arg1:T6 Arg2:T5	
R3	Has_qualifier Arg1:T9 Arg2:T8	
R4	Has_qualifier Arg1:T9 Arg2:T7	
R5	Has_qualifier Arg1:T9 Arg2:T6	
R6	AND Arg1:T9 Arg2:T10	
R7	AND Arg1:T15 Arg2:T16	
R8	AND Arg1:T12 Arg2:T13	
R9	AND Arg1:T11 Arg2:T15	
R10	Has_temporal Arg1:T15 Arg2:T14	
R11	AND Arg1:T12 Arg2:T15	
T1	Person 0 3	Men
T2	Person 8 13	women
T3	Person 14 18	aged
T4	Value 19 29	> 18 years
T5	Procedure 31 47	Angiographically
T6	Qualifier 31 57	Angiographically confirmed
T7	Qualifier 58 63	acute
T8	Qualifier 64 71	massive
T9	Condition 72 90	pulmonary embolism
T10	Condition 96 137	involvement of Central pulmonary arteries
T11	Condition 140 186	endovascular mechanical thrombus fragmentation
T12	Procedure 189 209	thrombolytic therapy
T13	Drug 217 260	recombinant tissue activator of plasminogen
T14	Temporal 329 371	in less than 48 hours before randomization
T15	Procedure 277 286	treatment
T16	Condition 310 328	pulmonary embolism
T18	Post-eligibility 520 561	ritten informed consent signed by patient
T19	Non-representable 373 517	The patient should be randomized no earlier than 24 hours after procedures endovascular mechanical thrombus fragmentation + thrombolytic therapy
